0001968202-23-000004.txt : 20230329
0001968202-23-000004.hdr.sgml : 20230329
20230329160707
ACCESSION NUMBER: 0001968202-23-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230327
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 23775262
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-03-27
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
1
Common Stock
2023-03-27
4
M
0
800
381.92
A
32905
D
Common Stock
2023-03-27
4
F
0
589
825.17
D
32316
D
Common Stock
2023-03-27
4
M
0
3000
378.98
A
35316
D
Common Stock
2023-03-27
4
F
0
2204
825.17
D
33112
D
Common Stock
2023-03-27
4
S
0
39
819.47
D
33073
D
Common Stock
2023-03-27
4
S
0
50
820.46
D
33023
D
Common Stock
2023-03-27
4
S
0
48
821.39
D
32975
D
Common Stock
2023-03-27
4
S
0
18
822.57
D
32957
D
Common Stock
2023-03-27
4
S
0
4
824.3
D
32953
D
Common Stock
2023-03-27
4
S
0
13
825.59
D
32940
D
Common Stock
2023-03-27
4
S
0
4
829.16
D
32936
D
Common Stock
2023-03-27
4
S
0
7
830.01
D
32929
D
Common Stock
2023-03-28
4
S
0
10
818.81
D
32919
D
Common Stock
2023-03-28
4
S
0
115
820.85
D
32804
D
Common Stock
2023-03-28
4
S
0
142
821.4
D
32662
D
Common Stock
2023-03-28
4
S
0
128
822.67
D
32534
D
Common Stock
2023-03-28
4
S
0
181
823.6
D
32353
D
Common Stock
2023-03-28
4
S
0
157
824.54
D
32196
D
Common Stock
2023-03-28
4
S
0
243
825.37
D
31953
D
Common Stock
2023-03-28
4
S
0
31
826.36
D
31922
D
Common Stock
250
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
378.98
2023-03-27
4
M
0
3000
0.0
D
2027-12-12
Common Stock
3000
20337
D
Non-Qualified Stock Option (right to buy)
381.92
2023-03-27
4
M
0
800
0.0
D
2026-12-16
Common Stock
800
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.
Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2023-03-29